Aptose Strengthens Board of Directors with Appointment of Bernd R. Seizinger, M.D., Ph.D. Market News
Health Canada Approves KEYTRUDA® as Adjuvant Treatment for Adults and Children with Stage IIB or IIC Melanoma Following Complete Resection Life Science Investing
AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE Market News
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union Life Science Investing
Astellas, Seagen and Merck Announce Results of Clinical Trial Investigating PADCEV® with KEYTRUDA® and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer Life Science Investing
Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® with KEYTRUDA® and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer Life Science Investing
BioHarvest Sciences to Webcast Live at VirtualInvestorConferences.com September 15th Life Science Investing
Awakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis Technology to Conduct Feasibility Studies to Improve Differentiation of Its MDMA Program Company News
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
